Expertise in
1
conditions

Chuntao H. Liu

Chengdu, CN 
Expertise in
1
conditions
Chengdu, CN 

Overview

Chuntao Liu practices practicing medicine in Chengdu, China.

Liu is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Asthma, Ozena, Allergic Rhinitis, and Eosinophilic Asthma.

They are actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 2 clinical trials.

Locations

Chengdu, 610041, China
Other Locations
Beijing, 100020, China
Beijing 100020, ChinaChen Wei Is Studying At Graduate School, Weifang, 261000, China
Department Of Otorhinolaryngology Head And Neck Surgery, Beijing, 100020, China
China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Device, Drug
Study Drugs: FF/VI, FF/UMEC/VI
Study Phase: Phase 3
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Salbutamol
Study Phase: Phase 3
View 1 Less Clinical Trial

76 Total Publications

Development of a prototype multi-scale turbulence coherent scattering diagnostic system based on far-infrared lasers on the HL-3 tokamak.
Development of a prototype multi-scale turbulence coherent scattering diagnostic system based on far-infrared lasers on the HL-3 tokamak.
Journal: The Review of scientific instruments
Published: December 05, 2025

Frequently Asked Questions about Chuntao H. Liu

Is Chuntao H. Liu a top-rated expert for Asthma?

MediFind is an objective health platform that identifies experts based on real-world data. Chuntao H. Liu is classified as an Advanced expert for Asthma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chuntao H. Liu participate in research or clinical trials?

Yes. Chuntao H. Liu has published 76 articles and abstracts on conditions like Asthma. You can view a list of Chuntao H. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile